News
Pharmaceutical Technology on MSN3d
EC authorises Eisai and Biogen’s lecanemab for Alzheimer’sEisai and Biogen have received marketing authorisation (MA) from the European Commission (EC) for Leqembi (lecanemab) to ...
UNHCR, the UN Refugee Agency works to ensure that everybody has the right to seek asylum and find safe refuge, having fled violence, persecution or war at home. Since 1950, we have faced multiple ...
A drug that targets an underlying cause of Alzheimer's disease being commercialized by Eisai and Biogen has received marketing approval from the European Commission.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback